Suboxone® Lawsuit Update
Hundreds of patients using Suboxone® to treat opioid dependence have taken legal action for severe tooth decay and other dental problems related to the medication. New developments continue to take place as victims await compensation and justice. Stay informed with the latest Suboxone lawsuit updates.
Why Take Legal Action?
By filing a dangerous drug lawsuit, you can pursue financial compensation and justice from the companies that caused you or a loved one harm.
Results Secured
- $1.75 million for a woman who suffered a pulmonary embolism from the birth control medication Yaz®
- $1.39 million for a woman in Florida who experienced severe side effects from the arthritis drug Vioxx®
- Over $600,000 for injuries related to Abilify® in New York
Suboxone Tooth Decay Lawsuit Update
Many victims who have suffered oral health problems from taking Suboxone and other buprenorphine medicines have filed legal claims against the companies that manufactured these products.
Even though the U.S. Food and Drug Administration (FDA) warned about the risk of tooth damage linked to Suboxone in January 2022, the label on Suboxone Sublingual Film wasn’t updated until months later. Some victims say they wouldn’t have used Suboxone if they had been informed.
As of September 2024, nearly 700 claims have been consolidated in a Suboxone class action lawsuit or multidistrict litigation (MDL) by those who have been harmed. Additional Suboxone lawsuits have been filed individually.
LawFirm.com is providing this Suboxone lawsuit update to keep those awaiting justice aware of the latest developments.
If you haven’t taken action yet, don’t delay. You only have a limited amount of time to file a claim for compensation. Take the first step toward justice now with a free case review.
Suboxone Lawsuit 2024 Update
Our Suboxone lawsuit update includes key events that have occurred as this litigation has moved through the legal system. By getting the latest news, consumers can get an idea of where the lawsuit is in the legal process and what they may be able to expect.
1. Companies Dismissed From Litigation
Suboxone Lawsuit Update: September 27, 2004
The two main companies being sued are pharmaceutical companies Indivior Inc. and Aquestive Therapeutics Inc. These defendants did not adequately warn about the dental risks linked to Suboxone film, according to the claims in the Suboxone MDL.
In mass tort cases like this one, plaintiffs typically name the primary company responsible, along with any related companies and subsidiaries, as they may have played a role in the alleged harm.
The court has dismissed these companies from the case: Indivior PLC, Reckitt Benckiser LLC, and Reckitt Benckiser Healthcare (UK) Ltd.
2. Utah Man Files New Suboxone Dental Injuries Lawsuit
Suboxone Tooth Decay Lawsuit Update: September 10, 2024
A Utah man has filed a Suboxone lawsuit in federal court, alleging he developed injuries from a sublingual film version of the opioid use disorder medication. He claims Suboxone’s acidic formulation led to permanent dental damage, including tooth decay and erosion.
The lawsuit cites a January 2022 FDA warning about serious dental problems linked to buprenorphine-based medications. Suboxone didn’t include these warnings until June 2022, and even then, they were inadequate, the suit says.
The man is seeking compensation for medical bills and to punish the defendants for allegedly concealing the drug’s risks to prioritize profits over patient safety.
3. Suboxone Bellwether Trials Discussed
Suboxone Lawsuit Update: September 9, 2024
The court and attorneys for both sides have begun discussing the plan for bellwether trials in the Suboxone litigation.
These trials are test cases that allow both sides to see how the litigation may progress, and they’re likely to influence Suboxone settlement amounts.
4. Suboxone Claims in MDL Rise to 674
Suboxone Tooth Decay Lawsuit Update: September 3, 2024
The total number of claims consolidated in the Suboxone class action MDL has reached 674, with the possibility of hundreds more being added before the filing deadline expires.
The FDA has identified over 300 cases of dental problems linked to buprenorphine medications dissolved in the mouth. The actual number of victims who have experienced adverse events from the use of Suboxone tablets and film may be much higher.
There’s a limited amount of time for victims to take legal action. Once the deadline in your case passes, you won’t be able to seek compensation for your injuries.
Call (888) 726-9160 right now or chat with a case manager for free so you don’t miss out on the compensation and justice you deserve.
5. MDL Judge Appoints Lawyers to Plaintiffs’ Leadership Committee
Suboxone Lawsuit Update: August 16, 2024
Judge J. Philip Calabrese is overseeing the legal claims consolidated in the Suboxone class action mass tort in the U.S. District Court for the Northern District of Ohio. He has appointed seven new lawyers to the Plaintiffs’ Leadership Development Committee (LDC).
The LDC plays an important role in large, complex litigation like the Suboxone class action lawsuit. The committee helps develop the legal strategy for the plaintiffs, identify expert witnesses, and manage the pre-trial exchange of information between the parties.
6. Tolling Agreement Explored
Suboxone Class Action Lawsuit Update: August 9, 2024
The tolling agreement, which would suspend or pause the running of the statute of limitations in the case for a certain period, continues to be discussed. The defendants have drafted a proposed stipulation for the other side to approve.
The tolling agreement is important as it will impact how long victims have to take legal action and seek compensation for Suboxone dental decay and tooth loss.
The statute of limitations in some states is 2 years. Suboxone labels were changed in June 2022, so the deadline for filing would be June 2024. Plaintiffs’ attorneys are pushing to extend this deadline, which would give all victims a chance to pursue justice.
Patients in all states should contact LawFirm.com as soon as possible while there’s still time to pursue compensation.
7. Defendants Attempt to Dismiss Suboxone Lawsuits
Suboxone Lawsuit Update: July 31, 2024
The Suboxone defendants have filed a motion to dismiss all claims against them, citing the doctrine of federal preemption. This defense is commonly raised in product liability lawsuits involving prescription drugs.
The defendants argue that the plaintiffs cannot sue drug manufacturers under state law for failure to warn when federal FDA regulations control the content of prescription drug warning labels.
This is an attempt by Suboxone’s manufacturers to dodge their legal responsibilities and avoid paying money to those they’ve harmed.
8. Court Sets Deadlines for Discovery
Suboxone Tooth Decay Lawsuit Update: July 24, 2024
Judge Calabrese has set two separate deadlines for the gathering and exchanging of information related to the Suboxone class action lawsuit.
- August 16, 2024: Both parties must submit information showing a sample of claimants and what’s needed to resolve the litigation.
- August 27, 2024: Proposals from both parties must be submitted to the court.
An efficient discovery process can help both parties access the information they need and move the case toward a settlement or trial, providing justice to those who have been harmed by the side effects of prescription Suboxone film.
9. Parties Dispute Electronic Discovery Order
Suboxone Lawsuit Update: July 16, 2024
Attorneys for both sides disagree as to how electronic documents should be handled and produced in Suboxone cases.
The defendants’ lawyers want each document to be evaluated individually, while the plaintiffs’ attorneys say that would be too complicated and time-consuming.
10. Court Rejects Defendants’ Motion Related to Causation
Suboxone Class Action Lawsuit Update: June 24, 2024
General causation refers to whether Suboxone is capable of causing the type of injuries that plaintiffs are claiming.
Defendants wanted the discovery process to focus only on this issue first, which could delay other important aspects like looking into individual cases and how the drug was marketed. Plaintiffs opposed this, arguing it would unnecessarily slow things down.
The court agreed with the plaintiffs, ruling that it’s better to handle everything together rather than in separate parts, ensuring a quicker and more streamlined process. For victims, this means they may be able to access the compensation they deserve faster.
Get a free case review now to see if a Suboxone lawyer in our network may be able to fight for compensation on your behalf.
11. Suboxone MDL Exceeds 350 Cases
Suboxone Lawsuit Update: June 3, 2024
The number of new cases in the Suboxone class action MDL is rising quickly. Last month, 153 new cases were added, marking the second consecutive month with over 100 new cases.
The total number of pending cases in the MDL has now reached 358.
12. Suboxone MDL Judge Issues Pre-Trial Orders
Suboxone Lawsuit Update: May 21, 2024
Judge Calabrese issued a set of orders to streamline the pre-trial process and ensure that the Suboxone MDL is handled efficiently.
These orders include rules for motion filings, expert witness disclosures, and discovery deadlines.
13. Two More Tooth Decay Lawsuits Filed
Suboxone Tooth Decay Lawsuit Update: April 25, 2024
A man from Prince George’s County, Maryland, filed a lawsuit alleging that he developed severe dental damage and tooth decay from using Suboxone to treat opioid addiction.
Like many Suboxone lawsuits, the complaint accuses Invidior of neglecting to provide information on the risk of dental problems to consumers and prescribing health care providers.
Earlier in the month, a Georgia woman filed a claim alleging that she underwent multiple tooth extractions and has ongoing dental problems due to using Suboxone film to treat her opioid addiction from 2016-2021.
14. MonoSol Dismissed From Litigation
Suboxone Lawsuit Update: April 4, 2024
MonoSol Rx, one of the companies behind Suboxone’s dissolvable film technology, is dismissed from the Suboxone tooth decay lawsuit.
MonoSol had been linked to the Suboxone antitrust case a few years back due to its partnership with Indivior. Indivior, the manufacturer of Suboxone, was accused of using the film version of the medication to block generics through a tactic called “product hopping.”
The lawsuit claimed this strategy violated antitrust laws by keeping drug prices high and limiting competition. Indivior faced significant fines for these actions, but MonoSol was also dismissed from that case.
Get a free case review now to see if a Suboxone lawyer may be able to fight for compensation on your behalf.
Suboxone Litigation News & Timeline
The first Suboxone tooth decay lawsuit was filed in 2023, and since then, hundreds of other patients have taken legal action. Learn about important moments in the Suboxone litigation.
- January 2022: The FDA issued a warning about serious dental issues, including tooth decay, associated with buprenorphine-based medications like Suboxone.
- June 2022: In response to the FDA’s warning, the label on Suboxone’s film was updated nearly 6 months later to include information about potential dental risks.
- September 2023: Patients who suffered from severe dental problems from Suboxone use started filing lawsuits, claiming Indivior and Aquestive Therapeutics failed to adequately warn about the risks.
- November 2023: Plaintiffs’ lawyers petitioned the Judicial Panel on Multidistrict Litigation to consolidate Suboxone lawsuits in a mass tort in the Northern District of Ohio.
- February 2024: As more victims began to come forward, the request for a Suboxone class action lawsuit or MDL was approved.
- March 2024: The first MDL status conference was held by Judge J. Philip Calabrese, who’s overseeing the Suboxone litigation.
- August 2024: The film version of Suboxone results in negative effects on the user’s oral and dental health, according to a study published in the Journal of the American Medical Association.
- September 2024: The number of cases in the Suboxone class action lawsuit has continued to climb, with nearly 700 claims alleging severe dental damage pending.
LawFirm.com will continue to provide Suboxone lawsuit updates, so victims know what they can expect as the litigation moves forward toward a potential settlement.
Get Help From a Suboxone Lawyer
LawFirm.com works with dangerous drug attorneys who are at the forefront of Suboxone litigation.
The Suboxone lawyers in our network have the resources to take on powerful pharmaceutical companies and even the playing field for everyday people with buprenorphine dental issues.
Our legal partners:
- Can help Suboxone users in all 50 states
- Don’t charge any upfront or hourly fees
- Have a proven track record of success
Together, they’ve secured over $1.6 billion for those harmed by dangerous drugs and medical devices.
Call (888) 726-9160 right now or get a free case review to see if they may be able to pursue compensation on your behalf.
New Suboxone Lawsuit Update FAQs
What is going on with the Suboxone lawsuit?
As of September 2024, 674 claims have been consolidated in a Suboxone class action lawsuit or multidistrict litigation (MDL) in the Northern District of Ohio.
The cases in the MDL allege that Suboxone lacked adequate warnings about the risk of tooth decay and other dental health issues.
New Suboxone claims continue to be filed as those harmed seek compensation for their dental treatments, pain and suffering, and more.
How do I get my money from a Suboxone lawsuit?
LawFirm.com may be able to help you seek compensation from a Suboxone tooth decay lawsuit.
The Suboxone lawyers in our network can handle every step of the legal process, fighting for the money you deserve while you go about your regular routine.
Get a free case review now to see if you may qualify.
Is it too late to join the Suboxone lawsuit?
No, it’s not too late to join the Suboxone lawsuit and pursue the compensation and justice you deserve for dental problems caused by buprenorphine medicines.
Suboxone lawsuits have filing deadlines called statutes of limitations, so it’s important to reach out to a personal injury attorney as soon as possible.
Call (888) 726-9160 now to see if we can connect you with a top Suboxone attorney.
What’s the Suboxone class action lawsuit update?
As of September 2024, the number of cases in the Suboxone multidistrict class action lawsuit continues to rise, with nearly 700 victims alleging severe dental damage and oral infections from Suboxone film.
Sublingual buprenorphine has been approved as an opioid addiction treatment, but it’s also been linked to loss of tooth enamel, tooth fractures, root canals, and other dental problems.
Fact-Checked and Legally Reviewed by: Rae Theodore
Rae Theodore is a writer and editor with more than 30 years of experience in legal publishing. She earned a bachelor’s degree in English from Pennsylvania State University.
- Harvard Health Publishing. (2024, August 8). “5 myths about using Suboxone to treat opiate addiction.” Retrieved September 27, 2024, from https://www.health.harvard.edu/blog/5-myths-about-using-suboxone-to-treat-opiate-addiction-2018032014496
- U.S. Food and Drug Administration. (2022, January 12). “FDA warns about dental problems with buprenorphine medicines dissolved in the mouth to treat opioid use disorder.” Retrieved September 27, 2024, from https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-about-dental-problems-buprenorphine-medicines-dissolved-mouth-treat-opioid-use-disorder
- Sokolove Law. (2024, September 18). “Suboxone lawsuit.” Retrieved September 27, 2024, from https://www.sokolovelaw.com/dangerous-drugs/suboxone/
- Substance Abuse and Mental Health Services Administration. (2024, March 28). “Buprenorphine.” Retrieved September 27, 2024, from https://www.samhsa.gov/medications-substance-use-disorders/medications-counseling-related-conditions/buprenorphine
- U.S. Judicial Panel on Multidistrict Litigation. (2024, September 3). “MDL Statistics Report – Distribution of Pending MDL Dockets by District.” Retrieved September 27, 2024, from https://www.jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_District-September-3-2024.pdf